Bicarbonate

Bicarbonate

SCHEMBL236872

O=C(O)O.O=C(O)c1ccccc1OCc1ccccc1.O=C(O)c1ccccc1OCc1ccccc1

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SGMS2 Q8NHU3 3/20 0.64
FOLH1 Q04609 1/20 0.62
PTGER1 P34995 1/20 0.61
ALDH1A1 P00352 5/20 0.61
KMT2A Q03164 2/20 0.61
PTK2B Q14289 1/20 0.61
HTT P42858 2/20 0.60
NPC1 O15118 1/20 0.60
GAA P10253 1/20 0.59
KDM4E B2RXH2 2/20 0.59
PARP1 P09874 1/20 0.57
L3MBTL1 Q9Y468 2/20 0.56
MCL1 Q07820 1/20 0.56
LMNA P02545 1/20 0.56
MAPT P10636 1/20 0.56
POLB P06746 1/20 0.56
MEN1 O00255 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL29914194 1.00 SGMS2 (0.64) SGMS2FOLH1PTGER1ALDH1A1KMT2A
Bicarbonate SCHEMBL21753662 1.00 SGMS2 (0.64) SGMS2FOLH1PTGER1ALDH1A1KMT2A
SCHEMBL29433417 0.98 SGMS2 (0.66) SGMS2FOLH1PTGER1ALDH1A1KMT2A
SCHEMBL112903 0.98 SGMS2 (0.66) SGMS2FOLH1PTGER1ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL8998291 0.96 SGMS2 (0.64) SGMS2FOLH1PTGER1ALDH1A1KMT2A
SCHEMBL17799483 0.96 SGMS2 (0.64) SGMS2FOLH1PTGER1ALDH1A1KMT2A
Ethyne SCHEMBL29820055 0.95 SGMS2 (0.62) SGMS2FOLH1PTGER1ALDH1A1KMT2A
SCHEMBL5839516 0.90 NR4A1 (0.63) SGMS2FOLH1PTGER1ALDH1A1PARP1
SCHEMBL27610143 0.89 GAA (0.64) SGMS2FOLH1PTGER1ALDH1A1KMT2A
SCHEMBL8786705 0.89 SGMS2 (0.64) SGMS2FOLH1PTGER1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600116-B2 Special polymer layers for faster laminability of multilayer structures COVESTRO DEUTSCHLAND AG (DE) 2026-04-14 US disclosed
EP-3055342-B1 PROCESS FOR PREPARING POLYSILOXANE-POLYCARBONATE BLOCK COCONDENSATES USING A SALT OF A WEAK ACID COVESTRO DEUTSCHLAND AG (DE) 2026-03-04 EP disclosed
US-12365775-B2 Process for partial colouring of plastic parts using solid colourants in colour- carrier layers COVESTRO DEUTSCHLAND AG (DE) 2025-07-22 US disclosed
US-20250205963-A1 METHOD FOR PRODUCING A PLASTIC MOLDING tooz technologies GmbH (DE) 2025-06-26 US disclosed
EP-4549163-A2 IMPROVED METHOD FOR PARTIAL COLOURING OF PLASTIC PARTS Covestro Deutschland AG (DE) 2025-05-07 EP disclosed
EP-2593288-B2 APPARATUS AND PROCESS FOR PRODUCING PRODUCTS FROM PIGMENT-CONTAINING POLYMER MIXTURES COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2025-04-16 EP disclosed
US-20250091332-A1 FILM STRUCTURE SUITABLE FOR RAPID LAMINATION COVESTRO DEUTSCHLAND AG (DE) 2025-03-20 US disclosed
EP-3055344-B1 POLYSILOXANE-POLYCARBONATE BLOCK COCONDENSATES COVESTRO DEUTSCHLAND AG (DE) 2025-03-12 EP disclosed
EP-3840958-B1 IMPROVED METHOD FOR PARTIAL COLOURING OF PLASTIC PARTS COVESTRO DEUTSCHLAND AG (DE) 2025-02-19 EP disclosed
EP-4493388-A1 METHOD FOR PRODUCING A PLASTIC MOLDING tooz technologies GmbH (DE) 2025-01-22 EP disclosed
EP-1742983-A1 PROCESS FOR PRODUCING POLYCARBONATE Bayer MaterialScience AG (DE) 2007-01-17 EP disclosed
EP-1692205-A1 METHOD FOR PRODUCING POLYCARBONATES HAVING A LOW CONTENT OF VOLATILE COMPOUNDS ACCORDING TO THE TRANSESTERIFICATION PROCESS Bayer MaterialScience AG (DE) 2006-08-23 EP disclosed
US-7091302-B2 Process for the preparation of polycarbonate BAYER MATERIALSCIENCE AG (DE) 2006-08-15 US disclosed
US-20060004178-A1 Inhibition of catalytically active impurities in polycarbonate by the melt transesterification process COVESTRO DEUTSCHLAND AG (DE) 2006-01-05 US disclosed
EP-1612231-A1 Inhibition of catalyst-active impurities in polycarbonate transesterification process Bayer MaterialScience AG (DE) 2006-01-04 EP disclosed
US-20050288407-A1 Thermally stabilized polycarbonate composition BAYER MATERIALSCIENCE AG 2005-12-29 US disclosed
EP-1609818-A2 Heat stabilised polycarbonate compositions Bayer MaterialScience AG (DE) 2005-12-28 EP disclosed
WO-2005103115-A1 PROCESS FOR PRODUCING POLYCARBONATE BAYER MATERIALSCIENCE AG (DE) 2005-11-03 WO disclosed
US-20050239995-A1 Process for the preparation of polycarbonate BAYER MATERIALSCIENCE AG 2005-10-27 US disclosed
WO-2005054335-A1 METHOD FOR PRODUCING POLYCARBONATES HAVING A LOW CONTENT OF VOLATILE COMPOUNDS ACCORDING TO THE TRANSESTERIFICATION PROCESS BAYER MATERIALSCIENCE AG (DE) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12600116-B2 Special polymer layers for faster laminability of multilayer structures ASH2L, SMC2, ELL SGMS2 1567/4885FOLH1 4369/4885PTGER1 2279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.